Valetudo Therapeutics LLC
CIK: 0002067359
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIMN
Liminatus Pharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Valetudo Therapeutics LLC
Valetudo Therapeutics LLC (SEC CIK 0002067359) files insider reports with the SEC as 10% Owner of Liminatus Pharma, Inc. (LIMN).
Signal8 holds 3 ownership filings by Valetudo Therapeutics LLC (1 Form 3, 2 Form 4), filed between Jun 16, 2025 and Jul 14, 2026. Those filings report 2 transactions, from Jun 24, 2026 to Jul 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Valetudo Therapeutics LLC's filings is in FULLERTON, CA.
Recent filings by Valetudo Therapeutics LLC
Other insiders filing for Liminatus Pharma, Inc. (LIMN)
- Ewon Comfortech Co., Ltd., 10% Owner
- Iris Acquisition Holdings LLC, 10% Owner
- Lemons II Philip Wayne, Director
- Baek Richard JaiHwan, Director
- KH Feelux Co., Ltd, 10% Owner
- Lee Eun Sook, Director